Birchview Capital’s Veracyte VCYT Stock Holding History

Birchview Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,767	Closed	-$301K	–	52
2019 Q4	$301K	Sell	10,767 -5,000	-32%	-$129K	0.22%	43
2019 Q3	$378K	Sell	15,767 -15,000	-49%	-$399K	0.25%	33
2019 Q2	$877K	Sell	30,767 -4,000	-12%	-$99.9K	0.53%	20
2019 Q1	$870K	Sell	34,767 -14,000	-29%	-$267K	0.55%	20
2018 Q4	$613K	Hold	48,767	–	–	0.58%	22
2018 Q3	$466K	Sell	48,767 -50,000	-51%	-$551K	0.3%	36
2018 Q2	$922K	Sell	98,767 -20,000	-17%	-$141K	0.63%	18
2018 Q1	$660K	Hold	118,767	–	–	0.43%	19
2017 Q4	$776K	Hold	118,767	–	–	0.45%	18
2017 Q3	$1.04M	Buy	118,767 +20,000	+20%	+$163K	0.54%	13
2017 Q2	$823K	Buy	98,767 +4,000	+4%	+$32.6K	0.44%	16
2017 Q1	$870K	Buy	94,767 +15,000	+19%	+$123K	0.48%	15
2016 Q4	$617K	Buy	79,767 +45,200	+131%	+$338K	0.38%	16
2016 Q3	$263K	Buy	+34,567	New	+$195K	0.15%	31

Other funds holding VCYT

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Birchview Capital's VCYT Position: Q1 2020 in Review

Birchview Capital sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 10,767 shares — an estimated $301K sold.

Birchview Capital first reported a position in VCYT in Q3 2016 and held it in 14 quarters. The position peaked at $1.04M in Q3 2017. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

Birchview Capital reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
Birchview Capital sold 10,767 Veracyte shares in Q1 2020, an estimated $301K.
Birchview Capital first reported a position in Veracyte in Q3 2016 and held it in 14 quarters.
Birchview Capital's Veracyte position peaked at $1.04M in Q3 2017.
165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on Birchview Capital's 13F filing for Q1 2020, filed 12 May 2020.